A carbamazepine trial in chronic, treatment-refractory schizophrenia
- PMID: 3285702
- DOI: 10.1176/ajp.145.6.748
A carbamazepine trial in chronic, treatment-refractory schizophrenia
Abstract
Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
